Clinical trials
Recruiting Non-alcoholic Fatty Liver Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2013 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 13 |
| 2025 | 12 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 6 |
| Regeneron Pharmaceuticals | 4 |
| Yale University | 3 |
| 89bio, Inc. | 2 |
| Bettina Mittendorfer | 2 |
| Columbia University | 2 |
| Mayo Clinic | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| University of California, San Diego | 2 |
| University of California, San Francisco | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 51 |
| Fatty Liver | 14 |
| Obesity | 11 |
| Fibrosis | 10 |
| Diabetes Mellitus, Type 2 | 7 |
| Insulin Resistance | 7 |
| Liver Cirrhosis | 5 |
| Liver Diseases | 5 |
| Metabolic Diseases | 3 |
| Prediabetic State | 3 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.